Chathur Acharya

Chathur Acharya

Auto-generated profile, based on publicly available information

Chathur Acharya

Division of Gastroenterology, Hepatology and Nutrition Virginia Commonwealth University and McGuire VA Medical Center Richmond VA USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2023 in Hepatology Communications
Verified
Journal Article
Open access
JSJawaid Shaw
Jawaid Shaw
CAChathur Acharya
Chathur Acharya
SASomaya Albhaisi
Somaya Albhaisi
AFAndrew Fagan
Andrew Fagan
SMSara McGeorge
Sara McGeorge
JBJasmohan Bajaj
Jasmohan Bajaj
Background: App-based technologies could enhance patient and caregiver communication and provide alerts that potentially reducing readmissions. However, the burden of App alerts needs to be optimized to reduce provider burnout. Aim: The purpose of this study was to determine subjective and objective burden of using the Patient Buddy App, a health information technology (HIT) on providers in a randomized multicenter trial, who completed a semi-quantitative Likert scale survey regarding training procedures, data and privacy concerns, follow-up details, and technical support. This randomized multicenter trial recruits cirrhosis inpatients and their caregivers, and randomizes them into standard-of-care, HIT (communication only via App) and HIT+visits (App+phone calls/visits) for 30 days after discharge. The alerts are monitored by providers through a central iPad. The reason(s) and number of alerts were recorded as the objective burden. A total of 1442 messages were sent as alerts from the 103 dyads (patient + caregiver) (n=206) randomized to HIT arms. The most common messages related to Hepatic Encephalopathy (HE) (high or low bowel movement=50% or orientation tests=37%). Twelve providers completed the surveys reflecting the following themes—92% and 100%, felt adequately trained and confident about educating the patients and caregivers before roll out of App and had no concerns related to data and privacy; 70%, felt that appropriate time was spent on pursuing reason for data not being logged; 60% each, had issues with availability of adequate technical support and connectivity. Conclusion: The Patient Buddy App randomized multicenter trial till date shows an overall favorable rating regarding training procedures/education, privacy concerns, and ease of message follow-up, from providers. However, it is important to gauge and address subjective and objective burdens of monitoring human resources in current and future HIT studies to avoid burnout and to ensure successful study completion.

9 April 2021 in Journal of Medical Internet Research
Verified
Journal Article
Open access
CAChathur Acharya
Chathur Acharya
TSTejasav S Sehrawat
Tejasav S Sehrawat
DMDeborah B McGuire
Deborah B McGuire
JSJawaid Shaw
Jawaid Shaw
AFAndrew Fagan
Andrew Fagan
JBJasmohan Bajaj
Jasmohan Bajaj
Background: Health information technology (IT) interventions to decrease readmissions for cirrhosis may be limited by patient-associated factors. Objective: The aim of this study was to determine perspectives regarding adoption versus refusal of health IT interventions among patient-caregiver dyads. Methods: Inpatients with cirrhosis and their caregivers were approached to participate in a randomized health IT intervention trial requiring daily contact with research teams via the Patient Buddy app. This app focuses on ascites, medications, and hepatic encephalopathy over 30 days. Regression analyses for characteristics associated with acceptance were performed. For those who declined, a semistructured interview was performed with themes focused on caregivers, protocol, transport/logistics, technology demands, and privacy. Results: A total of 349 patient-caregiver dyads were approached (191 from Virginia Commonwealth University, 56 from Richmond Veterans Affairs Medical Center, and 102 from Mayo Clinic), 87 of which (25%) agreed to participate. On regression, dyads agreeing included a male patient (odds ratio [OR] 2.08, P=.01), gastrointestinal bleeding (OR 2.3, P=.006), or hepatic encephalopathy admission (OR 2.0, P=.01), whereas opioid use (OR 0.46, P=.03) and alcohol-related etiology (OR 0.54, P=.02) were associated with refusal. Race, study site, and other admission reasons did not contribute to refusing participation. Among the 262 dyads who declined randomization, caregiver reluctance (43%), perceived burden (31%), technology-related issues (14%), transportation/logistics (10%), and others (4%), but not privacy, were highlighted as major concerns. Conclusions: Patients with cirrhosis admitted with hepatic encephalopathy and gastrointestinal bleeding without opioid use or alcohol-related etiologies were more likely to participate in a health IT intervention focused on preventing readmissions. Caregiver and study burden but not privacy were major reasons to decline participation. Reducing perceived patient-caregiver burden and improving communication may improve participation. Trial Registration: ClinicalTrials.gov NCT03564626; https://www.clinicaltrials.gov/ct2/show/NCT03564626

6 February 2020 in GastroHep
Verified
Journal Article
Closed access
PDF file
JBJasmohan Bajaj
Jasmohan Bajaj
CAChathur Acharya
Chathur Acharya
MSMasoumeh Sikaroodi
Masoumeh Sikaroodi
PGPatrick M. Gillevet
Patrick M. Gillevet
LTLeroy R. Thacker
Leroy R. Thacker

11 April 2018 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
CAC. Acharya
C. Acharya
JBJasmohan Bajaj
Jasmohan Bajaj

28 September 2020 in JMIR Preprints
Verified
Preprint
Open access
CAChathur Acharya
Chathur Acharya
TSTejasav S Sehrawat
Tejasav S Sehrawat
DMDeborah B McGuire
Deborah B McGuire
JSJawaid Shaw
Jawaid Shaw
AFAndrew Fagan
Andrew Fagan
JBJasmohan Bajaj
Jasmohan Bajaj
BACKGROUND Health information technology (IT) interventions to decrease readmissions for cirrhosis may be limited by patient-associated factors. OBJECTIVE The aim of this study was to determine perspectives regarding adoption versus refusal of health IT interventions among patient-caregiver dyads. METHODS Inpatients with cirrhosis and their caregivers were approached to participate in a randomized health IT intervention trial requiring daily contact with research teams via the Patient Buddy app. This app focuses on ascites, medications, and hepatic encephalopathy over 30 days. Regression analyses for characteristics associated with acceptance were performed. For those who declined, a semistructured interview was performed with themes focused on caregivers, protocol, transport/logistics, technology demands, and privacy. RESULTS A total of 349 patient-caregiver dyads were approached (191 from Virginia Commonwealth University, 56 from Richmond Veterans Affairs Medical Center, and 102 from Mayo Clinic), 87 of which (25%) agreed to participate. On regression, dyads agreeing included a male patient (odds ratio [OR] 2.08, P=.01), gastrointestinal bleeding (OR 2.3, P=.006), or hepatic encephalopathy admission (OR 2.0, P=.01), whereas opioid use (OR 0.46, P=.03) and alcohol-related etiology (OR 0.54, P=.02) were associated with refusal. Race, study site, and other admission reasons did not contribute to refusing participation. Among the 262 dyads who declined randomization, caregiver reluctance (43%), perceived burden (31%), technology-related issues (14%), transportation/logistics (10%), and others (4%), but not privacy, were highlighted as major concerns. CONCLUSIONS Patients with cirrhosis admitted with hepatic encephalopathy and gastrointestinal bleeding without opioid use or alcohol-related etiologies were more likely to participate in a health IT intervention focused on preventing readmissions. Caregiver and study burden but not privacy were major reasons to decline participation. Reducing perceived patient-caregiver burden and improving communication may improve participation. CLINICALTRIAL ClinicalTrials.gov NCT03564626; https://www.clinicaltrials.gov/ct2/show/NCT03564626

16 June 2022 in Gastroenterology
Verified
Journal Article
Closed access
JBJasmohan Bajaj
Jasmohan Bajaj
ASAmirhossein Shamsaddini
Amirhossein Shamsaddini
AFAndrew Fagan
Andrew Fagan
RSRichard K. Sterling
Richard K. Sterling
CAChathur Acharya
Chathur Acharya
PGPatrick M. Gillevet
Patrick M. Gillevet